These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17673129)

  • 1. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
    Ylli D; Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
    Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
    Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
    Lassmann M; Reiners C; Luster M
    Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies, Consensus, and Collaboration in the Use of
    Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
    Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiated thyroid cancer in children: diagnosis and management.
    Dinauer CA; Breuer C; Rivkees SA
    Curr Opin Oncol; 2008 Jan; 20(1):59-65. PubMed ID: 18043257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of dosimetry in the treatment of differentiated thyroid cancer.
    Lassmann M; Hänscheid H; Verburg FA; Luster M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):107-15. PubMed ID: 21386785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine therapy of differentiated thyroid cancer. Recommendations of the Therapy Study Group of the German Society of Nuclear Medicine].
    Georgi P; Emrich D; Heidenreich P; Moser E; Reiners C; Schicha H
    Nuklearmedizin; 1992 Aug; 31(4):151-3. PubMed ID: 1518724
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative use of radioiodine (131-I): review of recommendations and guidelines.
    Prpić M; Jukić T; Murgić J; Borić M; Stanicić J; Kusić Z
    Coll Antropol; 2011 Jun; 35(2):587-94. PubMed ID: 21755735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redifferentiating agents in non-radioiodine avid cancer.
    Seregni E; Vellani C; Castellani MR; Maccauro M; Pallotti F; Scaramellini G; Guzzo M; Greco A
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):513-9. PubMed ID: 19910904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine ablation for differentiated thyroid cancer-none, one dose or two?
    Rees GJ
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):131-5. PubMed ID: 19969444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of thyroid carcinoma using radioiodine].
    Santora J; Nĕmec J; Kubinyi J
    Cas Lek Cesk; 2001 Apr; 140(7):217-9. PubMed ID: 11374227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
    Al-Shakhrah IA
    Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.